Rapid responses are electronic comments to the editor. They enable our users
to debate issues raised in articles published on bmj.com. A rapid response
is first posted online. If you need the URL (web address) of an individual
response, simply click on the response headline and copy the URL from the
browser window. A proportion of responses will, after editing, be published
online and in the print journal as letters, which are indexed in PubMed.
Rapid responses are not indexed in PubMed and they are not journal articles.
The BMJ reserves the right to remove responses which are being
wilfully misrepresented as published articles or when it is brought to our
attention that a response spreads misinformation.
From March 2022, the word limit for rapid responses will be 600 words not
including references and author details. We will no longer post responses
that exceed this limit.
The word limit for letters selected from posted responses remains 300 words.
The Faculty of Pharmaceutical Medicine has long advocated the registration and timely publication of clinical trial results. The Faculty recently recommended to the House of Commons Science and Technology Select Committee Inquiry into Clinical Trials that trial results should be made available in the public domain within 12 months of study completion. We are pleased to see that this policy was adopted by the BMA at their annual conference held recently in Edinburgh and we strongly encourage pharmaceutical physicians and all doctors involved in medical research to strive to this standard.
Re: Publish all trial results within a year or face disciplinary action, BMA says
The Faculty of Pharmaceutical Medicine has long advocated the registration and timely publication of clinical trial results. The Faculty recently recommended to the House of Commons Science and Technology Select Committee Inquiry into Clinical Trials that trial results should be made available in the public domain within 12 months of study completion. We are pleased to see that this policy was adopted by the BMA at their annual conference held recently in Edinburgh and we strongly encourage pharmaceutical physicians and all doctors involved in medical research to strive to this standard.
Competing interests: No competing interests